Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

INTI

Inhibitor Therapeutics, Inc.

USD

Set alert

Price alert · INTI

All alert types
0.10 USD +0.03 +49.23%
As of Oct 30, 2026
0.0611 Day range 0.0611
0.04 52-week range 0.124
YTD
+115.56%
1 year
+94.00%
Open
0.0611
Prev close
0.065
Mkt cap
16.95M
Vol
90.00K
Avg vol
9.01K
EPS
-0.02
P/E
0.00
More statistics
Low
0.0611
High
0.0611

5D chart

Chart tools
Interval
1m5m15m30m
INTI five-day price chart0.060.070.070.080.083:15 PM3:25 PM3:35 PM3:45 PM3:55 PM4:00 PM

Financial health

Altman Z-Score

-139.03 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -2.4×
FY 2016: -16.1×FY 2017: -18.1×FY 2018: -4.9×FY 2019: -7.7×FY 2020: -12.5×FY 2021: -115×FY 2022: 3.0×FY 2023: -4.6×FY 2024: -3.1×FY 2025: -2.4×
FY 2016 5y median -3.1× FY 2025
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -6.0×
FY 2016: 16.0×FY 2017: 552×FY 2018: 686×FY 2019: -7.6×FY 2020: -3.9×FY 2021: -15.6×FY 2022: 4.4×FY 2023: 2.6×FY 2024: 5.2×FY 2025: -6.0×
FY 2016 5y median 2.6× FY 2025
P/FCF -2.4×
FY 2016: -30.0×FY 2017: -31.6×FY 2018: -6.0×FY 2019: -7.1×FY 2020: -15.8×FY 2021: -256×FY 2022: 3.1×FY 2023: -5.2×FY 2024: -3.2×FY 2025: -2.4×
FY 2016 5y median -3.2× FY 2025
EV/EBITDA -1.6×
FY 2016: 4762×FY 2017: 5084×FY 2018: 1479×FY 2019: 1244×FY 2020: 13078×FY 2021: -434×FY 2022: -333946×FY 2023: 13.4×FY 2024: 14.9×FY 2025: -1.6×
FY 2016 5y median -1.6× FY 2025
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -41.6%
FY 2016: -3.3%FY 2017: -3.2%FY 2018: -16.7%FY 2019: -14.0%FY 2020: -6.3%FY 2021: -0.4%FY 2022: 32.4%FY 2023: -19.4%FY 2024: -31.2%FY 2025: -41.6%
FY 2016 5y median -19.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 255.5%
FY 2016: -99.6%FY 2017: -3062.5%FY 2018: -14064.5%FY 2019: 107.4%FY 2020: 31.5%FY 2021: 8.3%FY 2022: 145.9%FY 2023: -57.3%FY 2024: -168.2%FY 2025: 255.5%
FY 2016 5y median 8.3% FY 2025
ROIC -193.6%
FY 2016: -99.6%FY 2017: -3062.5%FY 2018: -854.7%FY 2019: -586.1%FY 2020: 401.7%FY 2021: 83.4%FY 2022: -5.6%FY 2023: -41.1%FY 2024: -73.4%FY 2025: -193.6%
FY 2016 5y median -41.1% FY 2025
ROA -131.4%
FY 2016: -95.4%FY 2017: -664.1%FY 2018: -369.0%FY 2019: -302.1%FY 2020: -802.2%FY 2021: -508.6%FY 2022: 101.1%FY 2023: -33.8%FY 2024: -58.6%FY 2025: -131.4%
FY 2016 5y median -58.6% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income 6.3%
FY 2016: -77.8%FY 2017: 27.1%FY 2018: 10.8%FY 2019: 39.8%FY 2020: 61.5%FY 2021: 69.3%FY 2022: -102.5%FY 2023: -417.5%FY 2024: -7.4%FY 2025: 6.3%
FY 2016 FY 2025
EPS (diluted) 1.5%
FY 2016: -42.4%FY 2017: 42.6%FY 2018: 11.5%FY 2019: 40.7%FY 2020: 61.6%FY 2021: 53.6%FY 2022: 2407.7%FY 2023: -158.7%FY 2024: -10.2%FY 2025: 1.5%
FY 2016 FY 2025
Free Cash Flow 0.1%
FY 2016: -66.0%FY 2017: 22.5%FY 2018: -27.3%FY 2019: 27.0%FY 2020: 69.5%FY 2021: 73.3%FY 2022: 5426.2%FY 2023: -123.0%FY 2024: -19.7%FY 2025: 0.1%
FY 2016 FY 2025

Financial Health

Current Ratio 3.2×
FY 2016: 23.4×FY 2017: 1.1×FY 2018: 1.6×FY 2019: 2.0×FY 2020: 0.3×FY 2021: 0.1×FY 2022: 17.6×FY 2023: 13.5×FY 2024: 8.0×FY 2025: 3.2×
FY 2016 5y median 8.0× FY 2025
Quick Ratio 3.2×
FY 2016: 23.4×FY 2017: 1.1×FY 2018: 1.6×FY 2019: 2.0×FY 2020: 0.3×FY 2021: 0.1×FY 2022: 17.6×FY 2023: 13.5×FY 2024: 8.0×FY 2025: 3.2×
FY 2016 5y median 8.0× FY 2025
Debt / Equity -0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -0.0×FY 2021: -0.1×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2016: -310×FY 2017: -19.1×FY 2018: -77.8×FY 2019: -54.0×FY 2020: 21.6×FY 2021: -1.5×FY 2022: 155949×FY 2023: -23.3×FY 2024: -17.6×FY 2025: 0.7×
FY 2016 5y median -1.5× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -21.9×FY 2022: -28.3×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.3%FY 2019: 0.5%FY 2020: 0.8%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -1.2%FY 2019: -3.6%FY 2020: -9.5%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31